sgRNAs, recombinant plasmids, and cell lines for upregulating expression of human Dlk1-dio3 imprinted domain non-coding RNAs
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ZHEJIANG UNIV
- Publication Date
- 2020-12-08
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to gene editing and its application, in particular to a dedicated sgRNA primer sequence for up-regulating the expression of non-coding RNA in the DLK1-DIO3 imprinting domain and its application.
[0002] technical background
[0003] Gene editing technology is a genome modification technology developed in recent years, which can perform InDel mutation, knock-in, multi-site mutation, small fragment deletion, and fragment replacement at specific sites in the genome. In the field of scientific research, gene editing technology can be used for the rapid construction of model organisms, such as the construction of specific gene knockout mice; in the field of agriculture, this technology can be used for the optimization of animal and plant varieties; It is possible to treat diseases from the source by modifying human's own genes. Therefore, gene editing technology has extremely wide application value and development prospects. ...